Major Scope

  •  Colon and Rectal Surgery
  •  General Surgery
  •  Gynecologic Oncology
  •  Plastic Surgery
  •  Neurological Surgery
  •  Orthopaedic Surgery
  •  Orthopaedic Surgery of the Spine
  •  Neonatal Surgery
  •  Prenatal Surgery
  •  Trauma Surgery
  •  Surgical Intensivists, Specializing In Critical Care Patients
  •  Thoracic Surgery
  •  Congenital Cardiac Surgery
  •  Thoracic Surgery-Integrated
  •  Vascular Surgery

Abstract

Citation: Clin Surg. 2021;6(1):3084.Research Article | Open Access

Medico-Economic Impact of the AirSeal® Insufflator: Example of Laparoscopic Sacrocolpopexy

Boualaoui I*, Bey E, De Villeneuve MH, Dergamoun H, Droupy S and Wagner L

Department of Urology and Andrology, Nimes University Hospital Center, France

*Correspondance to: Boualaoui I 

 PDF  Full Text DOI: 10.25107/2474-1647.3084

Abstract

Introduction: AirSeal? is an insufflation system that enables a stable pneumoperitoneum during laparoscopic surgery, thus providing a permanent renewal of the abdominal gas in a closed system. The aim of this study was to evaluate the medical and economic impact of the AirSeal? system for laparoscopic sacrocolpopexy. Materials and Methods: A preliminary mono-centric retrospective study has been performed during a period of 9 months between May 2019 and February 2020. Post-operative pain was evaluated by a visual analog scale on days 0, 1, and 2. Analgesic and antiemetic use was also collected. The main intraoperative anesthesiologic parameters (morphine and curare doses, peak airways pressure, endtidal CO2 , and temperature) were also studied. The patient?s outing ability was evaluated by the CHUNG score. Results: Thirty-four consecutive patients treated by laparoscopic sacrocolpopexy have been included in the present study. The first 17 were operated using the AirSeal? system and the other half using a standard insufflating system, by the same surgeon. Mean age was 58.9 ? 12.2 years. Postoperative pain was lower in the AirSeal? system group with 40% of morphinic use vs. 52% in the standard system group. The length of stay was also shorter, with 65% of AirSeal? system patients able to leave on an ambulatory basis vs. 35% in the second group, and 95% on first day vs. 76% in the standard insufflation system group. Conclusion: These preliminary results may suggest a positive medical and economic impact of the AirSeal? insufflation system by reducing length of stay, postoperative pain and analgesic use.

Keywords

Sacrocolpopexy; Low impact laparoscopy; laparoscopy; Postoperative pain

Cite the article

Boualaoui I, Bey E, De Villeneuve MH, Dergamoun H, Droupy S, Wagner L. Medico-Economic Impact of the AirSeal® Insufflator: Example of Laparoscopic Sacrocolpopexy. Clin Surg. 2021; 6: 3084.

Journal Basic Info

  • Impact Factor: 2.395**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
  • NLM ID: 101702548

Search Our Journal

Journal Indexed In

Articles in PubMed

Monitoring an Ongoing Enhanced Recovery after Surgery (ERAS) Program: Adherence Improves Clinical Outcomes in a Comparison of Three Thousand Colorectal Cases
 PubMed  PMC  PDF  Full Text
Mesh Sprayer Device with Liquefied Mesh Delivery System: Proposed Alternative for Currently Available Meshes in Hernia Repair and Supplement to Abdominal Closure
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

ACE2 - Molecular Speculations on Abdominal Symptoms after COVID-19 Infection
 Abstract  PDF  Full Text
Could Collaboration between Emergency Department Clinicians and Dentists More Effectively Treat Patients with Acute Dental Pain?
 Abstract  PDF  Full Text
View More...